April 17, 2026 · Neurourology and urodynamics · DOI: 10.1002/nau.70292

Evaluating Outcomes of Sacral Neuromodulation in Patients With Multiple Sclerosis

Listen to this summary

The authors aimed to evaluate the impact of multiple sclerosis (MS) on the revision and removal rates of sacral neuromodulation (SNM) devices, using a large national dataset. Their findings indicate that patients with MS have similar rates of device revision/removal and complications compared to controls without neurological disorders, suggesting that MS does not adversely affect SNM outcomes.

Murat Yavuz Koparal, Stephen Rhodes, David Sheyn, Adonis Hijaz

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play